Ingredient

Imatinib Mesylate

Imatinib Mesylate is an antineoplastic agent that inhibits the growth of certain cancer cells.

See medicines used for Others & Special
All medicines
26
Single ingredient
26
Prescription medication
26

MFDS ingredient code M253530

What does it do?

Imatinib Mesylate belongs to the class of antineoplastic agents known as tyrosine kinase inhibitors. It is primarily used for the treatment of chronic myeloid leukemia and some gastrointestinal stromal tumors, blocking the abnormal signaling in cancer cells.

This ingredient inhibits the activity of a specific enzyme called tyrosine kinase within cancer cells, disrupting the processes by which cancer cells proliferate and divide. This helps slow down or stop the growth of cancer cells.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other antineoplastic agents, Imatinib Mesylate acts selectively on cancer cells with specific genetic mutations as a targeted therapy. This results in relatively fewer side effects and effective treatment.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

26 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.